BIOMAT Database Logo BIOMAT Database Logo

Thymidine kinase and cancer monitoring. 2012

Stefan Aufderklamm, and Tilman Todenhöfer, and Georgios Gakis, and Stephan Kruck, and Joerg Hennenlotter, and Arnulf Stenzl, and Christian Schwentner
Department of Urology, Eberhard-Karls University, Tubingen, Germany.

Thymidine kinases (TK) have a key function in the synthesis of DNA. Two isoenzymes have been characterized: TK1 is cell cycle-dependent and present in the cytoplasm whereas TK2--located in mitochondria--is cell cycle-independent. The diagnostic and prognostic role of TK1 has recently been investigated. TK1 might be helpful for screening and monitoring of human malignancies. TK1 may also serve as a prognostic factor for progression. Herein, we summarize the status of TK1 for cancer monitoring and point out its use as a proliferation marker. A comprehensive overview about the association of TK-1 with various entities is given.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013937 Thymidine Kinase An enzyme that catalyzes the conversion of ATP and thymidine to ADP and thymidine 5'-phosphate. Deoxyuridine can also act as an acceptor and dGTP as a donor. (From Enzyme Nomenclature, 1992) EC 2.7.1.21. Deoxythymidine Kinase,Deoxypyrimidine Kinase,Kinase, Deoxypyrimidine,Kinase, Deoxythymidine,Kinase, Thymidine
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers

Related Publications

Stefan Aufderklamm, and Tilman Todenhöfer, and Georgios Gakis, and Stephan Kruck, and Joerg Hennenlotter, and Arnulf Stenzl, and Christian Schwentner
Thymidine kinase, DNA synthesis and cancer.
June 1976, Molecular and cellular biochemistry,
Stefan Aufderklamm, and Tilman Todenhöfer, and Georgios Gakis, and Stephan Kruck, and Joerg Hennenlotter, and Arnulf Stenzl, and Christian Schwentner
Thymidine kinase in breast cancer.
October 1990, British journal of cancer,
Stefan Aufderklamm, and Tilman Todenhöfer, and Georgios Gakis, and Stephan Kruck, and Joerg Hennenlotter, and Arnulf Stenzl, and Christian Schwentner
Preoperative Serum Thymidine Kinase Activity as Novel Monitoring, Prognostic, and Predictive Biomarker in Pancreatic Cancer.
January 2018, Pancreas,
Stefan Aufderklamm, and Tilman Todenhöfer, and Georgios Gakis, and Stephan Kruck, and Joerg Hennenlotter, and Arnulf Stenzl, and Christian Schwentner
[Serum thymidine kinase in the monitoring of lymphoma patients].
January 1995, Duodecim; laaketieteellinen aikakauskirja,
Stefan Aufderklamm, and Tilman Todenhöfer, and Georgios Gakis, and Stephan Kruck, and Joerg Hennenlotter, and Arnulf Stenzl, and Christian Schwentner
Thymidine plaque autoradiography of thymidine kinase-positive and thymidine kinase-negative herpesviruses.
January 1983, Journal of clinical microbiology,
Stefan Aufderklamm, and Tilman Todenhöfer, and Georgios Gakis, and Stephan Kruck, and Joerg Hennenlotter, and Arnulf Stenzl, and Christian Schwentner
Simultaneous determination of thymidylate and thymidine diphosphate by capillary electrophoresis as a rapid monitoring tool for thymidine kinase and thymidylate kinase activities.
June 2005, Electrophoresis,
Stefan Aufderklamm, and Tilman Todenhöfer, and Georgios Gakis, and Stephan Kruck, and Joerg Hennenlotter, and Arnulf Stenzl, and Christian Schwentner
Serum thymidine kinase levels in cancer patients.
August 1986, Irish journal of medical science,
Stefan Aufderklamm, and Tilman Todenhöfer, and Georgios Gakis, and Stephan Kruck, and Joerg Hennenlotter, and Arnulf Stenzl, and Christian Schwentner
[Thymidine kinase].
June 1970, Nihon rinsho. Japanese journal of clinical medicine,
Stefan Aufderklamm, and Tilman Todenhöfer, and Georgios Gakis, and Stephan Kruck, and Joerg Hennenlotter, and Arnulf Stenzl, and Christian Schwentner
Thymidine kinase.
December 1985, Microbiological sciences,
Stefan Aufderklamm, and Tilman Todenhöfer, and Georgios Gakis, and Stephan Kruck, and Joerg Hennenlotter, and Arnulf Stenzl, and Christian Schwentner
Clinical relevance of thymidine kinase for the diagnosis, therapy monitoring and prognosis of non-operable lung cancer.
May 2010, Anticancer research,
Copied contents to your clipboard!